Select Medical Holdings Corporation (NYSE:SEM) Receives Consensus Rating of “Moderate Buy” from Analysts

Shares of Select Medical Holdings Corporation (NYSE:SEM) have been assigned an average recommendation of “Moderate Buy” from the six brokerages that are covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating and four have issued a buy rating on the company. The average 12-month target price among analysts that have covered the stock in the last year is $17.80.

Several brokerages have recently commented on SEM. Weiss Ratings reiterated a “sell (d+)” rating on shares of Select Medical in a report on Wednesday, October 8th. Royal Bank Of Canada increased their price objective on shares of Select Medical from $16.00 to $20.00 and gave the company an “outperform” rating in a research note on Wednesday, October 8th. Benchmark restated a “buy” rating on shares of Select Medical in a research note on Monday, October 27th. Wall Street Zen raised Select Medical from a “hold” rating to a “buy” rating in a research report on Saturday, November 8th. Finally, Mizuho set a $17.00 price target on Select Medical in a report on Monday, November 3rd.

Select Medical Stock Performance

Shares of SEM opened at $15.21 on Friday. The firm has a market capitalization of $1.88 billion, a P/E ratio of 17.68, a P/E/G ratio of 0.54 and a beta of 1.26. Select Medical has a 52 week low of $11.65 and a 52 week high of $20.83. The stock has a 50 day moving average price of $14.79 and a two-hundred day moving average price of $13.86. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.09 and a current ratio of 1.09.

Select Medical (NYSE:SEM) last announced its earnings results on Thursday, October 30th. The health services provider reported $0.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.18 by $0.05. The company had revenue of $1.36 billion for the quarter, compared to analysts’ expectations of $1.33 billion. Select Medical had a return on equity of 7.41% and a net margin of 2.05%.Select Medical’s quarterly revenue was up 7.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.43 earnings per share. Select Medical has set its FY 2025 guidance at 1.140-1.240 EPS. Equities analysts forecast that Select Medical will post 1.17 earnings per share for the current fiscal year.

Select Medical Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, November 25th. Investors of record on Wednesday, November 12th were issued a $0.0625 dividend. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.6%. The ex-dividend date of this dividend was Wednesday, November 12th. Select Medical’s payout ratio is 29.07%.

Institutional Trading of Select Medical

Several hedge funds have recently added to or reduced their stakes in the stock. Dimensional Fund Advisors LP grew its position in shares of Select Medical by 4.2% during the 3rd quarter. Dimensional Fund Advisors LP now owns 5,197,343 shares of the health services provider’s stock valued at $66,731,000 after acquiring an additional 207,951 shares during the period. State Street Corp lifted its stake in Select Medical by 1.3% in the second quarter. State Street Corp now owns 4,253,793 shares of the health services provider’s stock valued at $64,573,000 after purchasing an additional 55,686 shares during the last quarter. Geode Capital Management LLC grew its holdings in Select Medical by 2.7% during the second quarter. Geode Capital Management LLC now owns 3,035,186 shares of the health services provider’s stock valued at $46,079,000 after purchasing an additional 80,425 shares during the period. 8 Knots Management LLC purchased a new stake in Select Medical in the second quarter worth $26,568,000. Finally, Bank of America Corp DE raised its stake in shares of Select Medical by 3.4% in the third quarter. Bank of America Corp DE now owns 1,673,302 shares of the health services provider’s stock valued at $21,485,000 after buying an additional 54,640 shares during the period. Institutional investors own 89.48% of the company’s stock.

Select Medical Company Profile

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.